PW Medtech Group (HKG:1358) expects an attributable profit of between 83 million yuan and 102 million yuan for the year 2025, down 32% to 45% from 150.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.
The medical device company attributed the forecast to a drop in sales in the infusion set segment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.